Public Health Agency of Canada

The Government of Canada and air industry continue collaboration to reduce wait times at airports across Canada

Retrieved on: 
Thursday, July 14, 2022
Safety, Interim order, Greater Toronto Airports Authority, Person, Advance, London International Airport, Canadian Transportation Agency, The Honourable, Twitter, Travel, Compliance, NAV CANADA, Airport, Canadian Air Transport Security Authority, CANADA, Instagram, Winnipeg James Armstrong Richardson International Airport, PHAC, YouTube, News, CBSA, Public security, Atmosphere, Windsor International Airport, Public Health Agency of Canada, Government, Toronto Pearson International Airport, CEO, Industry, Quarantine, Transport, Government of Canada, Public Health Agency, Pharmacy, Transport Canada, CATSA, Severe cognitive impairment, NAV, Vancouver International Airport, Gulf of Alaska, MRT, Vaccination, Solution, COVID-19, Congestion, Animal, Airline, Oil, Vaccine, Taxicab, Baggage, Facebook, Health, Tourism

Later that day, Minister Alghabra also visited the NAV CANADA air traffic control tower at Windsor International Airport.

Key Points: 
  • Later that day, Minister Alghabra also visited the NAV CANADA air traffic control tower at Windsor International Airport.
  • Last summer, NAV CANADA announced that the air traffic control tower at Windsor International Airport would be staying open.
  • On Wednesday, July 13 Minister Alghabra met with the CEO of Winnipeg International Airport to discuss the solutions they are implementing to mitigate congestion and wait times for their travellers.
  • We continue to work with air industry partners to reduce congestion and delays in the travel system and update Canadians on our progress.

Government of Canada is re-establishing mandatory random testing offsite of airports for air travellers

Retrieved on: 
Thursday, July 14, 2022
Toronto Pearson International Airport, Vancouver International Airport, Safety, Compliance, Pharmacy, Science, MRT, Travel, Government of Canada, Risk, CBSA, Atmosphere, Public Health Agency of Canada, COVID-19, Government, Quarantine, Public Health Agency, Calendar, Health, Vaccination, Airport, Vaccine, Airline, Animal, Pharmaceutical industry, Oil

The Government of Canada had paused mandatory random testing for those entering Canada by air on June 11, 2022, as part of a broader strategy to transition testing for air travellers outside of the airports.

Key Points: 
  • The Government of Canada had paused mandatory random testing for those entering Canada by air on June 11, 2022, as part of a broader strategy to transition testing for air travellers outside of the airports.
  • Mandatory random testing will resume as of July 19, 2022, for travellers who qualify as fully vaccinated, arriving in Canada by air to the four major Canadian airportsVancouver, Calgary, Montreal and Toronto.
  • All vaccinated travellers who are randomly selected for the border testing surveillance program must complete arrival mandatory testing requirements.
  • Pausing mandatory random (MRT) testing for air travellers was a temporary measure and part of a broader strategy to transition traveller testing for air travellers into the community.

SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)

Retrieved on: 
Tuesday, July 12, 2022
Annual report, Development, Smallpox, US Foods, Office of Inspector General, U.S. Department of Health and Human Services, Xi, Biomedical Advanced Research and Development Authority, Patient, Policy, Private Securities Litigation Reform Act, Human, PHAC, Infection, Cowpox, IV, EMA, CEO, BARDA, GLOBE, Patent, National security, Public Health Agency, DND, Virus, Risk, Forward-looking statement, Ix, Public Health Agency of Canada, Exercise, Vaccination, Contract, Monkeypox, Vii, Orthopoxvirus, COVID-19, European Medicines Agency, Phrase, FDA, SIGA Technologies, NASDAQ, Vaccinia, Vaccine, Health Canada, Human services, Documentation, Government, Project Bioshield Act, Assistant, U.S. Department of Defense Strategy for Operating in Cyberspace, Research

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced approximately $28 million of procurement orders for oral TPOXX® (tecovirimat), including approximately $2 million for initial procurement by two new international jurisdictions and approximately $26 million for procurement by Canada, of which approximately $22 million is being procured by the Public Health Agency of Canada (PHAC) and approximately $4 million is being procured by the Canadian Department of National Defence (DND) under existing contracts. One of the new jurisdictions is in Europe, and the other new jurisdiction is in the Asia Pacific region.  

Key Points: 
  • NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced approximately $28 million of procurement orders for oral TPOXX (tecovirimat), including approximately $2 million for initial procurement by two new international jurisdictions and approximately $26 million for procurement by Canada, of which approximately $22 million is being procured by the Public Health Agency of Canada (PHAC) and approximately $4 million is being procured by the Canadian Department of National Defence (DND) under existing contracts.
  • In combination with the approximately $13 million PHAC order that was previously disclosed on the last investor call, PHAC and DND have ordered approximately $39 million of oral TPOXX (tecovirimat) this year.
  • To date this year, SIGA has received approximately $56 million of international orders for oral TPOXX (tecovirimat) from six jurisdictions, of which five are new customers.
  • The increase over the last two months in international orders of oral TPOXX (tecovirimat) reflects an initial public health reaction to the evolving monkeypox outbreak, said Phil Gomez, CEO of SIGA.

Sleep Country Empowers Canadians to Improve Their Sleep with the Launch of All For Sleep App

Retrieved on: 
Tuesday, July 12, 2022
Learning, Party All Night (Sleep All Day), Sleep, App store, Sleep Country Canada, Solution, TSX, App store optimization, Partnership, CEO, Android, IOS, Insomnia, Public Health Agency, Diversified Specialty Institute Holdings, Inc., Theall, Louisiana, Ecosystem, Health, Relaxation, Public Health Agency of Canada, Mail order, Pharmaceutical industry

The new app gives users evidence-based sleep solutions and the tools to create their own personalized sleep program with leading-edge support to help improve their sleep habits and wellbeing.

Key Points: 
  • The new app gives users evidence-based sleep solutions and the tools to create their own personalized sleep program with leading-edge support to help improve their sleep habits and wellbeing.
  • "As Canada's sleep partner, we're thrilled to launch our new sleep app All for Sleep to support Canadians in getting the sleep they need to function at their best, both mentally and physically," said Stewart Schaefer, President and CEO of Sleep Country.
  • Our new sleep app will empower Canadians to focus on their sleep and give them the tools to sleep better and live better lives," added Schaefer.
  • The All For Sleep app is available for download on the App Store for iOS devices and on Google Play for Android devices.

Substance Use Expert and Family Physician New CEO of Canadian Centre on Substance Use and Addiction

Retrieved on: 
Tuesday, July 5, 2022
Department, Public Health Agency of Canada, Addiction medicine, Parliament, Research, ST, Government, GLOBE, COVID-19, Health Canada, Policy, University, Substance, Center, Hospital, Mental health, Government of Canada, Health, CCSA, Public Health Agency, Act of Parliament (UK), Solution, Joint task force, Knowledge, Pharmaceutical industry

OTTAWA, July 05, 2022 (GLOBE NEWSWIRE) -- Dr. Alexander Caudarella, a bilingual family physician specializing in substance use issues, will be the new CEO of the Canadian Centre on Substance Use and Addiction (CCSA) effective August 2022.

Key Points: 
  • OTTAWA, July 05, 2022 (GLOBE NEWSWIRE) -- Dr. Alexander Caudarella, a bilingual family physician specializing in substance use issues, will be the new CEO of the Canadian Centre on Substance Use and Addiction (CCSA) effective August 2022.
  • CCSA was created in 1988 by an Act of Parliament as a neutral, non-partisan and trusted national expert on substance use and addiction.
  • Dr. Caudarella has extensive experience and training in substance use and addiction medicine.
  • He has been a member and expert advisor for both the Ontario Health Mental Health and Addictions COVID-19 Recovery table and the Public Health Agency of Canadas substance use mortality technical group.

STATEMENT - Update on monkeypox in Canada - June 27, 2022

Retrieved on: 
Monday, June 27, 2022
Diagnosis, Women's Emergency Committee to Open Our Schools, Government of Canada, PHEIC, Research, Greater Sullivan County Public Health Network, Disease, Government, Monkeypox virus, National Microbiology Laboratory, IPC, Committee, Infection, NML, Health Canada, Awareness, World, Risk, Monkeypox, Public Health Emergency of International Concern, NACI, National Advisory Committee on Immunization, World Health Organization, International Health Regulations, Public Health Agency of Canada, Public Health Agency, Public health, IHR, PHAC, Vaccine, News, Public health emergency, WHO, Animal, Medical device, Immunization, Health

The Public Health Agency of Canada (PHAC) is issuing this statement to provide an update on its ongoing response to monkeypox.

Key Points: 
  • The Public Health Agency of Canada (PHAC) is issuing this statement to provide an update on its ongoing response to monkeypox.
  • The Government of Canada took immediate action upon the confirmation of the first cases in Canada.
  • OTTAWA, ON, June 27, 2022 /CNW/ - On June 23, 2022, the World Health Organization (WHO) Director General convened its International Health Regulations (IHR) Emergency Committee to discuss the multi-country outbreak of monkeypox.
  • Since the outset of the monkeypox outbreak, the Public Health Agency of Canada (PHAC) has been working with domestic and international partners to protect the health of everyone in Canada.

Joint Statement from the Co-Chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses - Latest National Data on Substance-Related Harms

Retrieved on: 
Thursday, June 23, 2022
Methamphetamine, Naloxone, Health, Public Health Agency, PHAC, Epidemic, COVID-19, Language, Risk, Death, Special Advisory Committee, Foundation, Cocaine, Friends, Homelessness, Leadership, Child, Drug, Publication, Public Health Agency of Canada, Pharmaceutical industry

OTTAWA, ON, June 23, 2022 /CNW/ -Today, the co-chairs of the federal, provincial and territorial Special Advisory Committee on the Epidemic of Opioid OverdosesDr.

Key Points: 
  • OTTAWA, ON, June 23, 2022 /CNW/ -Today, the co-chairs of the federal, provincial and territorial Special Advisory Committee on the Epidemic of Opioid OverdosesDr.
  • The latest data show that the number of opioid-related deaths remained high and continued to climb in 2021, with a total of 7,560 opioid-related deaths that year.
  • The number of opioid-related hospitalizations also grew from 13 per day in 2016, to 17 per day in 2021.
  • Substance-related harms affect people across Canada from all walks of life, but some populations have been affected more than others.

Duchesnay announces the launch of Vablys® (dequalinium chloride vaginal tablets), an antiseptic and anti-infective treatment for bacterial vaginosis

Retrieved on: 
Tuesday, June 21, 2022
Public Health Agency, Culture, Vaginal discharge, Irritation, Degenerative disease, Hotel manager, Chlamydia trachomatis, Public Health Agency of Canada, Bacterial vaginosis, Urology, Health Canada, Pregnancy, Personal lubricant, Papilloma, SERM, POP, HPV, Birth, Physician, Professional, GLOBE, Health, Acquisition, Vagina, Commercial Affairs Department, HIV, Patient, Columbia Centre, BV, Organization, Woman, Pharmaceutical industry, Birth control, Chlamydia, Duchesnay

Vablys is the first prescription antiseptic and anti-infective treatment for bacterial vaginosis in women under 55 years of age.

Key Points: 
  • Vablys is the first prescription antiseptic and anti-infective treatment for bacterial vaginosis in women under 55 years of age.
  • Vablys offers Canadian physicians and their patients the first gynecological anti infective and antiseptic prescription treatment option, said Gino Henry, Senior Manager, Commercial Affairs, at Duchesnay.
  • 1
    Vablys is the third new prescription treatment for Canadian women launched by Duchesnay in 2022, achieving an aggressive target set by the companys new management team.
  • According to the Public Health Agency of Canada, bacterial vaginosis is the most common cause of vaginal discharge in people of reproductive age.

Government of Canada and airport and airline partners making progress on reducing traveller wait times at Canada's major airports

Retrieved on: 
Wednesday, June 15, 2022
Solution, Industry, Vancouver International Airport, Public Health Agency, COVID-19, CATSA, The Honourable, Canada Border Services Agency, Greater Toronto Airports Authority, Government, Person, PHAC, Severe cognitive impairment, Public Health Agency of Canada, Toronto Pearson International Airport, Airport, YouTube, TC, Public security, News, COVID-19 testing, Social media, Twitter, Government of Canada, Communication, Instagram, Canadian Air Transport Security Authority, Transport, CBSA, Transport Canada, Animal, Airline, Taxicab, Health, Tourism, Facebook

We continue to work with airports, airlines, baggage handlers, and other partners to implement solutions to reduce delays as we approach the summer peak season.

Key Points: 
  • We continue to work with airports, airlines, baggage handlers, and other partners to implement solutions to reduce delays as we approach the summer peak season.
  • Current traveller wait times for pre-board passenger screening at Canadian airports continue to decrease.
  • "Actions currently underway by the Government of Canada and the air industry include:
    Hiring of CATSA screening officers continues.
  • CBSA and the Greater Toronto Airports Authority are making available additional kiosks at Toronto Pearson International Airport customs hall areas.

Coalese Health teams with Calian to bring automated chronic disease management software from medical clinics to hospitals

Retrieved on: 
Wednesday, June 15, 2022
Solution, Customer satisfaction, Public Health Agency, Learning, TSX, CEO, EMR, Hospital, Public Health Agency of Canada, Asthma, Confidence, Physician, AB, Health, Service delivery framework, Software, Patient, Conditional sentence, Degenerative disease, Diabetes, Health insurance

The two companies are working together to extend the benefits of Coalese Health's Complex Care Plan chronic disease management software beyond the primary care clinic, and into the hospital environment.

Key Points: 
  • The two companies are working together to extend the benefits of Coalese Health's Complex Care Plan chronic disease management software beyond the primary care clinic, and into the hospital environment.
  • Care plans for patients with chronic health conditions are at the core of any meaningful chronic disease management program.
  • "We're excited to collaborate with Coalese Health on this innovative solution to help hospitals connect the care journey and improve the management of chronic disease."
  • Using Coalese Health's Complex Care Plan software, physicians save significant time, which can then be better directed towards patient care.